The aim of this consultation was to address implementation challenges in Non-Communicable Diseases (NCDs) and prioritize actions for effective implementation.
After conducting 2 State level consultations with National Health Mission in 2017, Project HOPE and Eli Lilly and Company (India Pvt. Ltd.) successfully conducted the 3rd and final consultation at the national level. The aim of this consultation was to address implementation challenges in Non-Communicable Diseases(NCDs) and prioritize actions for effective implementation.
NCDs account for 61% of deaths in India each year (Global Burden of Diseases Report, 2016). They constitute a major public health challenge, impacting both the social and economic development of the country with substantial human costs.
Speaking on the occasion, Dr. Jitendra Singh, Minister of State in Prime Minister’s Office said, “I would like to congratulate Project HOPE for having organized this event. The subject of non-communicable diseases marks the march of India from one era of disease spectrum to another era. Currently, NCDs in India are facing challenges in terms of economic, social, cultural & lifestyle aspects."
Organizations like Project HOPE play a very important role to identify people who need help & educate them on social aspects. For economic and lifestyle aspects our present government is very sensitive & is going to launch Ayushman Bharat Yojana next month which will benefit 10 crore families with an insurance cover of Rs. 5 Lakh each.
The government has also started the process of wellness clinics all over the country & free dialysis unit in each of the hospitals, especially at district level. I am glad Project HOPE provided me with this platform where I can brainstorm & stimulate on issues like these.
Dr. Laxmikant Palo, Regional Director- SE Asia/Country Director-India, Project HOPE said, “Addressing the programme implementation challenges of Non-communicable diseases (NCDs) requires comprehensive solutions developed together by all key stakeholders. Project HOPE is working in partnership with government and key stakeholders to respond to the growing burden of NCDs in India.”
The purpose of these consultations was to bring together representatives from Government, national and international non-governmental organizations, civil societies, policy and program implementers, and private sector, to exchange and share their experiences and ideas about addressing operational challenges in implementing NCD programs.
Dr. Thomas Kenyon – CEO Project HOPE global said, “Project HOPE welcomes the opportunity to support this national-level consultation on lessons learned and how to accelerate the Government of India’s exemplary efforts to control the growing burden of non-communicable diseases."
These daunting challenges can only be overcome by mobilizing the power of partnerships to deliver life-saving evidence-based interventions to those in need. This meeting further demonstrates our commitment and spirit of collaboration and coordination to save lives.
Luca Visini, Managing Director, Eli Lilly, and Co. India said, “India currently faces a huge burden of Non-Communicable Diseases. There is a clear need for simpler screening process and technology needs to be leveraged for training physicians and healthcare workers." The consultation called on the Central and State Governments, along with other partners, to take this agenda for NCD action forward.